Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) in Patients With Head and Neck Tumor

Head and Neck Tumor Clinical Trial

Official title:
Phase I Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) With Patients With Head and Neck Tumor

Status Completed

Clinical Trial Summary

This study will evaluate the feasibility of higher and prolonged dose escalation concentrated in the intra-tumoral regions which are FDG-avid after two weeks of radiotherapy.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00406289
Study type	Interventional
Source	University Hospital, Ghent
Contact
Status	Completed
Phase	Phase 1
Start date	November 2006
Completion date	February 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT06016335` - MRI-based Synthetic CT Images of the Head and Neck	N/A
Recruiting	`NCT05053230` - A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer	N/A
Completed	`NCT01228448` - In-Room PET in Proton Radiation Therapy	N/A
Completed	`NCT04334239` - Effectiveness of Care in Certified Cancer Centres in Germany
Recruiting	`NCT05183243` - Dose Finding Study of GH21 in Adult Patients With Advanced Solid Tumors	Phase 1
Recruiting	`NCT04075305` - The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study